Title: [Analysis of designer drugs detected in the products purchased in fiscal year 2006].
Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20081001
1389313-40-9
15558-50-6
2452-25-7
73-31-4
28363-70-4
608-07-1
85405-03-4 | (R)-2-(Butyryloxy)-3-(hexadecyloxy)propyl (2-(trimethylammonio)ethyl) phosphate | AA00G6TR | MFCD02259312
811-73-4 | Trimethyliodostannane | AA00G7A7 | MFCD00019009
82155-85-9 | Boc-d-ser(bzl)-osu | AA00G7NM | MFCD00236873
842169-72-6 | 1-(4-Bromophenyl)-2,2,2-trifluoroethanamine hydrochloride | AA00G83G | MFCD08056077
82548-54-7 | tert-Butyl 2-(3-hydroxyphenyl)acetate | AA00G8PQ | MFCD19543462
7730-82-7 | 2-(Thiazol-5-yl)ethanamine dihydrochloride | AA00G9FL | MFCD27920700
854181-94-5 | 1-(4-methylphenyl)ethanamine, HCl | AA00G9KC | MFCD22383689
84761-04-6 | 4-Benzyl-2,2-dimethylmorpholine | AA00G9VJ | MFCD29920461
849770-44-1 | 1,5-Dimethylpyrrolidine-2,4-dione | AA00GA9T | MFCD19690648
76706-63-3 | 5,5a-Dihydro-1,5a,9,13-tetrahydroxy-3,7-dimethyl-4H,10H,12H,16H-dibenzo[de,d'e']furo[2,3-g | AA00GAZU